Quest Laboratories Limited - Due diligence report

A 360° intelligence report on Quest Laboratories Limited: trust score, financial health, credit view, compliance, directors, growth and dist…

1998-06-01 Dhar, Madhya Pradesh Active Unlisted Active Compliant
Share
View plans
QL Quest Laboratories Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Quest Laboratories Limited — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Quest Laboratories Limited is assessed as Low Risk with a Trust Score of 77/100. Quest Laboratories Limited is an active public limited indian non-government company incorporated in 1998, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 04 Jul 2026 from the latest processed filings. Quest Laboratories Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
30/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 5 open (32.30 cr) · 5 satisfied (4.11 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited3 48.0 cr
Others3 48.0 cr
Shriram City Union Finance Limited1 48.0 cr
Union Bank Of India3 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 30/100
NameDIN / PANDesignationAppointedTenureDIN status
ANIL KUMAR SABARWAL 01234567 Director 01/04/2018 6 yrs Approved
TEJASWINI CHOUHAN 01234567 Director 01/04/2018 6 yrs Approved
Amit Ramesh Chandak 01234567 Director 01/04/2018 6 yrs Approved
Umendra Singh 01234567 Director 01/04/2018 6 yrs Approved
Basant Lal Menghwani 01234567 Director 01/04/2018 6 yrs Approved
GAUTAM CHAND KOTHARI 01234567 Director 01/04/2018 6 yrs Approved
VINAYAK SABARWAL 01234567 Director 01/04/2018 6 yrs Approved
Ramkrishna Sharma 01234567 Director 01/04/2018 6 yrs Approved
Ayushi Taunk 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • GAUTAM CHAND KOTHARI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 5 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
17 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: ANIL KUMAR SABARWAL (Managing Director) · TEJASWINI CHOUHAN (Whole-time director) · Umendra Singh (Whole-time director) · VINAYAK SABARWAL (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 28+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 32.30 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
03 Oct 2025
Director appointed
Ayushi Taunk (Company Secretary)
26 Sep 2024
Charge created
Others - 90.00 Lakh
04 Sep 2024
Last AGM held
Annual general meeting
03 Sep 2024
Director ceased
Umendra Singh
Director ceased
VINAYAK SABARWAL
01 Jul 2024
Director appointed
Umendra Singh (Whole-time director)
Director appointed
VINAYAK SABARWAL (Whole-time director)
31 Mar 2024
Latest balance sheet
Filed with ROC
14 Mar 2024
Charge satisfied
Others
08 Feb 2024
Director ceased
Amit Ramesh Chandak
Director ceased
Basant Lal Menghwani
Director ceased
GAUTAM CHAND KOTHARI
17 Jan 2024
Director appointed
Ramkrishna Sharma (Cfo)
10 Jan 2024
Director appointed
Amit Ramesh Chandak (Director)
Director appointed
Basant Lal Menghwani (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
9 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 17 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Maxwell Life Science Limited U24230MH2004PLC146536 Borivali West, Maharashtra, India
Xl Laboratories U24239DL2000PTC104513 New Delhi, Delhi, India
Maxheal Pharmaceuticals (India) Limited U73100MH2009PLC193624 Mumbai, Maharashtra, India
Tripura Bio-Tech Limited U24219TG1997PLC114003 Yadadri Bhongir District, Telangana, India
Nava Healthcare Private Limited U24233DL2006PTC151081 New Delhi, Delhi, India
Curetech Formulations Private Limited U24232HP2003PTC026326 Himachal Pradesh, Himachal Pradesh, India
Macmillon Pharmaceuticals Private Limited U24231PB1988PTC008661 Punjab, Punjab, India
Apex Healthcare U24233GJ2007PLC049757 Surat, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Quest Laboratories Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Quest Laboratories Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Quest Laboratories Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Quest Laboratories Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Quest Laboratories Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Quest Laboratories Limited an active company?

Quest Laboratories Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Quest Laboratories Limited financially healthy?

Quest Laboratories Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Quest Laboratories Limited?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Quest Laboratories Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 9 active director(s) are on record.

Does Quest Laboratories Limited have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.

Is Quest Laboratories Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Quest Laboratories Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.